PURPOSE: We assessed the impact of type 2 diabetes, in the presence of other major cardiovascular risk factors, on coronary microvascular function and myocardial perfusion in patients without obstructive coronary artery disease (CAD). METHODS: In this prospective study, 23 patients with type 2 diabetes and 26 nondiabetic patients matched for age, sex and other cardiovascular risk factors underwent a cold pressure test (CPT) and dipyridamole transthoracic echocardiography to determine their coronary flow (CF) ratio. Within 2 weeks, all diabetic patients also underwent dipyridamole-rest myocardial perfusion single-photon emission (MPS) CT. None of the patients with or without diabetes had significant CAD on invasive coronary angiography. RESULTS: The CPT-CF ratio was significantly lower in diabetic patients than in nondiabetic patients (1.46 ± 0.26 vs. 1.71 ± 0.32, p = 0.006) and was correlated significantly with fasting glycaemia (r = -0.35, p = 0.01), but not with glycated haemoglobin. The dipyridamole-CF ratio was also lower in diabetic patients than in nondiabetic patients (2.38 ± 0.74 vs. 2.75 ± 0.49, p = 0.04). On MPS imaging, 5 diabetic patients (22%) had stress-induced ischaemia and the remaining 18 (78%) had normal myocardial perfusion. The dipyridamole-CF ratio was not different in patients with and without reversible defects (2.3 ± 1.1 vs. 2.4 ± 0.6, p = 0.97). CONCLUSION: Coronary microvascular function is impaired in type 2 diabetic patients without significant CAD, compared to nondiabetic patients with similar other cardiovascular risk factors. In the majority of diabetic patients, microvascular dysfunction is associated with normal myocardial perfusion.
PURPOSE: We assessed the impact of type 2 diabetes, in the presence of other major cardiovascular risk factors, on coronary microvascular function and myocardial perfusion in patients without obstructive coronary artery disease (CAD). METHODS: In this prospective study, 23 patients with type 2 diabetes and 26 nondiabeticpatients matched for age, sex and other cardiovascular risk factors underwent a cold pressure test (CPT) and dipyridamole transthoracic echocardiography to determine their coronary flow (CF) ratio. Within 2 weeks, all diabeticpatients also underwent dipyridamole-rest myocardial perfusion single-photon emission (MPS) CT. None of the patients with or without diabetes had significant CAD on invasive coronary angiography. RESULTS: The CPT-CF ratio was significantly lower in diabeticpatients than in nondiabeticpatients (1.46 ± 0.26 vs. 1.71 ± 0.32, p = 0.006) and was correlated significantly with fasting glycaemia (r = -0.35, p = 0.01), but not with glycated haemoglobin. The dipyridamole-CF ratio was also lower in diabeticpatients than in nondiabeticpatients (2.38 ± 0.74 vs. 2.75 ± 0.49, p = 0.04). On MPS imaging, 5 diabeticpatients (22%) had stress-induced ischaemia and the remaining 18 (78%) had normal myocardial perfusion. The dipyridamole-CF ratio was not different in patients with and without reversible defects (2.3 ± 1.1 vs. 2.4 ± 0.6, p = 0.97). CONCLUSION: Coronary microvascular function is impaired in type 2 diabeticpatients without significant CAD, compared to nondiabeticpatients with similar other cardiovascular risk factors. In the majority of diabeticpatients, microvascular dysfunction is associated with normal myocardial perfusion.
Authors: Tuomas O Kiviniemi; Jyri O Toikka; Juha W Koskenvuo; Antti Saraste; Markku Saraste; Jussi P Pärkkä; Olli T Raitakari; Jaakko J Hartiala Journal: Ultrasound Med Biol Date: 2007-03 Impact factor: 2.998
Authors: M F Di Carli; D Bianco-Batlles; M E Landa; A Kazmers; H Groehn; O Muzik; G Grunberger Journal: Circulation Date: 1999-08-24 Impact factor: 29.690
Authors: Roxana Campisi; Lauren Nathan; Miguel Hernandez Pampaloni; Heiko Schöder; James W Sayre; Gautam Chaudhuri; Heinrich R Schelbert Journal: Circulation Date: 2002-01-29 Impact factor: 29.690
Authors: Maurizio Galderisi; Silvana Cicala; Pio Caso; Luigi De Simone; Arcangelo D'Errico; Antonio Petrocelli; Oreste de Divitiis Journal: Am J Cardiol Date: 2002-10-15 Impact factor: 2.778
Authors: Kim L Ho; Qutuba G Karwi; David Connolly; Simran Pherwani; Ezra B Ketema; John R Ussher; Gary D Lopaschuk Journal: Diabetologia Date: 2022-01-07 Impact factor: 10.122
Authors: Suzanne V Arnold; John A Spertus; Kasia J Lipska; Fengming Tang; Abhinav Goyal; Darren K McGuire; Sharon Cresci; Thomas M Maddox; Mikhail Kosiborod Journal: Eur J Prev Cardiol Date: 2014-04-16 Impact factor: 7.804
Authors: Giuseppe Giugliano; Cinzia Perrino; Vittorio Schiano; Linda Brevetti; Anna Sannino; Gabriele Giacomo Schiattarella; Giuseppe Gargiulo; Federica Serino; Marco Ferrone; Fernando Scudiero; Andreina Carbone; Antonio Bruno; Bruno Amato; Bruno Trimarco; Giovanni Esposito Journal: BMC Surg Date: 2012-11-15 Impact factor: 2.102
Authors: Gaurav S Gulsin; Emer Brady; Anna-Marie Marsh; Gareth Squire; Zin Z Htike; Emma G Wilmot; John D Biglands; Peter Kellman; Hui Xue; David R Webb; Kamlesh Khunti; Tom Yates; Melanie J Davies; Gerry P McCann Journal: Ther Adv Endocrinol Metab Date: 2021-07-17 Impact factor: 3.565